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Crimean–Congo hemorrhagic fever virus (CCHFV), the fatal human pathogen is transmitted
to humans by tick bite, or exposure to infected blood or tissues of infected livestock. The
CCHFV genome consists of three RNA segments namely, S, M, and L. The unusual large
viral L protein has an ovarian tumor (OTU) protease domain located in the N terminus. It
is likely that the protein may be autoproteolytically cleaved to generate the active virus L
polymerase with additional functions. Identiﬁcation of the epitope regions of the virus is
important for the diagnosis, phylogeny studies, and drug discovery. Early diagnosis and
treatment of CCHF infection is critical to the survival of patients and the control of the
disease. In this study, we undertook different in silico approaches using molecular docking
and immunoinformatics tools to predict epitopes which can be helpful for vaccine design-
ing. Small molecule ligands against OTU domain and protein–protein interaction between
a viral and a host protein have been studied using docking tools.
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INTRODUCTION
Crimean–Congo hemorrhagic fever (CCHF) is a viral hemor-
rhagic fever of the Nairovirus group, primarily distinguished as
zoonosis. Occurrence rate of sporadic cases and outbreaks of
CCHF affecting humans have been reported. It has a history of
endemic infections in South Africa, Pakistan, Kosovo, Turkey,
United Arab Emirates and some parts of Asia. It is so named
because it was ﬁrst observed in Cremia of Congo in 1944 (WHO,
2011). It belongs to Bunyaviridae family of Nairovirus group. It
spreads in animals through ticks or ﬂeas and can infect human
beings through the animal reservoir (Whitehouse, 2004). CCHF
virus, abbreviated as CCHFV, recently noted in Gujarat, killing
four people, the ﬁrst outbreak reported in India. National Institute
of Virology (NIV), India conﬁrmed this outbreak and found to be
due to hyalomma ticks (International Society for Infectious Dis-
eases, 2011). The infected person normally develops febrile illness
with headache, joint, lumbar, and abdominal pain with nausea,
initially. After 3–5 days, hemorrhaging develops with skin discol-
oration and blood in saliva, urine, and vomit, leading to vascular
collapse and death around 10 days after onset (WHO, 2011).
Crimean–Congo hemorrhagic fever virus has a tripartite
genome consisting of large (L), medium (M), and small (S)
negative-sense RNA segments that encode the viral RNA poly-
merase, the glycoproteins, and the nucleocapsid protein (NP),
respectively (Clerx et al., 1981). Viral infection is detected by host
cells via Toll-like receptor (TLR)-dependent and -independent
mechanismswhich results in ubiquitination and ISGylation of tar-
get proteins to induce the innate immune system. Ubiquitination
involves a regulatory protein called Ubiquitin (Ub) which con-
jugates with target (viral) proteins and forms an Ub-tag which
in turn, recognized by proteosome for destruction (Staheli
et al., 2007). ISGylation engages an Ub-like molecule known as
interferon-stimulated gene product 15 (ISG15), which covalently
conjugates and induce innate response (Arguello and Hiscott,
2007). The viral L protein has an ovarian tumor (OTU) domain
of cysteine protease family, located in N terminus, is dispensable
for RNA-dependent RNA polymerase (RdRp) and deubiquitinat-
ing (DUB) activity. In order to invade host antiviral mechanisms
(Figure 1), OTU domain conjugates with Ub and ISG15 to estab-
lish viral state (Bergeron et al., 2010). It was also reported that host
system makes use of interferon (IFN) – induced defense mecha-
nism against a number of viruses belonging to Bunyaviridae. MxA
protein, a member of dynamin superfamily of large GTPases is
exclusively induced by alpha and beta IFNs (Haller and Kochs,
2002). It has been found thatMxA interactedwithNP and the yield
of progeny virus was reduced to 1,000-fold in CCHFV infected
host cells. Hence, it is clear that human MxA protein has antiviral
activity against CCFHV (Andersson et al., 2004). Current status
for the treatment of CCHFV infections utilizes ribavirin to combat
the infection (WHO, 2011). Treatment in infected individuals was
shown to exhibit the in vivo genotoxicity and potential side effects
caused by ribavirin (Tatar et al., 2005).
In the present study, in silico drug designing and immunoin-
formatics strategies have been exploited using bioinformatics
software and programs. Epitope-based immunoinformatics study
was carried out for NP in order to predict informative epitopes
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FIGURE 1 | Crimean–Congo hemorrhagic fever virus infection cycle. L, M, and S, viral genomic segments; GPC, glycoprotein complex; TLR, Toll-like
receptor; RdRp, RNA-dependent RNA polymerase; OTU domain, ovarian tumor domain; IFN, interferon; Ub, ubiquitin; ISG15, IFN simulated gene product 15.
which can be helpful for future vaccine designing. To examine the
protein–protein interaction and the background of biochemical
functionality between a viral and a host protein, protein–protein
docking analysis of NP with human MxA protein was performed
through structure-based approach. Finally, identiﬁcation of effec-
tive ligand molecules to inhibit viral OTU domain were made
using small molecule docking simulations.
MATERIALS AND METHODS
EPITOPE-BASED IMMUNOINFORMATICS STUDY OF NP
Protein sequence retrieval and epitope prediction parameters
Weretrieved the protein sequence of NPof CCHFV(AccessionNo.
AAX86921.1) from National Centre for Biotechnology Institute
(NCBI) database (Benson et al., 2005). The locations of continu-
ous epitopes have been correlated with various parameters (such
as hydrophilicity, ﬂexibility, accessibility, turns, exposed surface,
polarity, and antigenic propensity of polypeptide chain). The epi-
tope predictions are based on propensity scales for each of the 20
amino acids.
Assessment of solvent accessibility regions
The prediction for regions of surface accessibility is based on
Emini’s surface accessibility scale. Accessibility proﬁle is predicted
using the formula Sn = (i−1Π6δn + 4 + i) × (0.37)−6 where Sn
is the surface probability, δn is the fractional surface probability
value, and i vary from 1 to 6. A hexapeptide sequence with Sn
greater than 1.0 indicates an increased probability for being found
on the surface (Emini et al., 1985).
Epitope ﬂexibility prediction
To strengthen the prediction accuracy, we used the Karplus and
Schulz ﬂexibility scale. This scale is derived from the mobility of
protein segments based on the known temperature B factors of the
alpha carbons of 31 proteins of known structure. The calculation
is performed taking the center amino acid as the ﬁrst amino acid
of the six amino acid window length (threshold setting= 1.000;
Karplus and Schulz, 1985).
Prediction of antigenicity
Peptides could be predicted in such amanner that it should possess
the antigenic character and are likely to be antibody respon-
sive. Antigenicity prediction was carried out using Kolaskar and
Tongaonkar antigenicity scale. This prediction is based on a semi-
empirical approach, developed on physicochemical properties of
amino acid residues and their frequencies of occurrence in exper-
imentally known segmental epitopes and has the efﬁciency to
detect antigenic peptides with about 75% accuracy (threshold set-
ting= 1.000; Kolaskar and Tongaonkar, 1990). The location of
linear B-cell epitope was predicted using Bepipred linear epitope
predictionwhichutilizes a combinationof a hiddenMarkovmodel
and a propensity scale method (threshold setting= 0.350; Larsen
et al., 2006).
Hydrophobicity and hydrophilicity analysis
The amino acids making up the epitope are usually charged and
hydrophilic in nature. Parker hydrophilicity scale was applied to
evaluate the hydrophilicity. It is based on peptide retention time in
high-performance liquid chromatography (HPLC) on a reversed-
phase column. Using a window of seven residues, these experi-
mental values are calibrated for each of the seven residues and the
arithmetical mean of the seven residue value was assigned to the
fourth, (i + 3), residue in the segment (threshold setting= 1.678;
Parker et al., 1986).
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To understand the distribution of polar and apolar residues
along a protein sequence, hydrophobicity plot was studied using
Kyte–Doolittle hydropathicity index (threshold setting ≥0 are
hydrophobic) available at Expasy Protscale server (Gasteiger et al.,
2005). Kyte–Doolittle is a widely applied scale for delineat-
ing hydrophobic character of a protein and useful in predict-
ing membrane-spanning domains, potential antigenic sites, and
regions that are likely exposed on the protein surface (Kyte and
Doolittle, 1982).
HLA binding peptide prediction
Major histocompatibility complexes (MHC-I and MHC-II) dis-
play speciﬁcity for binding with their respective epitopes. In
human, these MHC molecules are known by human leukocyte
antigen (HLA) alleles. The HLA binding peptides were predicted
(threshold setting= 3.000) using TmhcPred server. This predic-
tion is based on the virtual and quantitative matrices based on 97
MHC alleles using position speciﬁc scoring matrices (PSSMs) and
utilizes supervised learningmethod called support vectormachine
(SVM; Bhasin et al., 2003).
Note that the predictions based on the above mentioned
scales viz. Emini, Karplus and Schulz, Kolaskar and Tongaonkar,
Bepipred linear epitope prediction and Parker are different web-
based tools centralized in a repository implemented by immune
epitope database and analysis resource (IEDB) for the prediction
and analysis of immune epitopes (Zhang et al., 2008).
STUDY ON PROTEIN–PROTEIN DOCKING OF HUMAN MxA- VIRAL NP
PROTEINS
Ab initio modeling of NP
An attempt was made to construct a homology model of NP
using Swiss Model (Schwede et al., 2003). No suitable template
was found by target-template alignment programs such as BLAST
and HHSearch with the signiﬁcant cutoffs for template identiﬁca-
tion (BLAST: e-value= 0.0001; HHSearch: e-value= 0.0001 and
p-value= 50). Therefore, an ab initio model was constructed using
Bhageerath server. Bhageerath, an energy based approach which
narrow downs the search space of tertiary structures employing
sequence and secondary structure information as building stage;
and later ﬁltered by atomic potential based biophysical method-
ology to present 10 plausible candidate structures (Jayaram et al.,
2006).
Structure validation and energy minimization of modeled NP
Modeled NP structure was validated for structure correctness
and stereochemistry using Ramachandran plot (Ramachandran
et al., 1963) from RAMPAGE server (Lovell et al., 2003). The
validated structure was subjected to energy minimization using
NOMAD-Ref server (Lindahl et al., 2006). Normal mode analy-
sis, deformation, and reﬁnement, abbreviated as NOMAD-Ref,
make use of elastic network model (ENM) as well as classical force
ﬁelds to calculate normal modes for structural reﬁnement and
optimization.
Functional site identiﬁcation of MxA protein
Theprotein structure of humanMxAprotein (Gao et al., 2010)was
retrieved from Protein Databank (PDB ID: 3LJB; Bernstein et al.,
1977). The MxA protein structure is comprised of two unique
chains, functional site identiﬁcation was carried out for a single
chain using ConSurf server (Ashkenazy et al., 2010). This enables
the identiﬁcation of functionally important regions on the sur-
face of a protein or domain of known three-dimensional protein
structure and relied on the phylogenetic relations between its close
sequence homologs.
Protein–protein docking
Protein–protein docking simulations were performed using global
range molecular matching (GRAMM)-X protein–protein dock-
ing web server v.1.2.0 (Tovchigrechko and Vakser, 2006). In this
process, optimal functional site of MxA protein deduced by Con-
Surf was implemented as potential interface region for docking
simulations in order to avoid blind search and modeled NP was
given as ligand input and best 10 returned docked conformations
were analyzed. GRAMM, an empirical approach which smoothes
the intermolecular energy function by changing the range of the
atom–atom potentials, locates the area of the global minimum
of intermolecular energy using a characteristic six-dimensional
exhaustive search through the relative translations and rotations
of the molecules. Moreover, this docking simulation was repeated
using ClusPro protein–protein docking program (Kozakov et al.,
2010). The program recruits PIPER, a FFT (Fast Fourier Trans-
form) based rigid docking program in its ﬁrst stage to generate
1,000 low energy docked conformations using pairwise interaction
potentials. In the second stage, ClusPro clusters these confor-
mations and retains 30 largest clusters having low energy. Later,
the retained clusters are analyzed by SDU (Semi-Deﬁnite pro-
gramming based Underestimation) program which predicts the
stability of the clusters using medium-range optimization algo-
rithm (resembling the funnel-like behavior of the free energy to
attain local minima) and the stable clusters are then reﬁned using
Monte-Carlo simulation.
STUDY ON PROTEIN-SMALL MOLECULE DOCKING OF VIRAL OTU
DOMAIN
Sequence retrieval and multiple sequence alignment to ﬁnd active
site
Active site of viral OTU domain was identiﬁed using multi-
ple sequence alignment (MSA) with human Ub-speciﬁc protease
otubains 1 and 2 (Accession No. AAO27702.1 and AAO27703.1).
Protein sequences were retrieved from NCBI (Benson et al., 2005)
and MSA was performed using EBI ClustalW program (Blosum
weighting matrix, gap opening penalty= 10 and gap extension
penalty= 0.1; Larkin et al., 2007). Further, active site pocket was
structurally analyzed using CASTp program (Dundas et al., 2006).
Preparation of protein target structure and ligand molecules
The protein structure of viral OTU domain protease (James et al.,
2011) was retrieved from PDB (ID: 3PT2). The dataset comprised
of four ligands having known inhibitory activity chosen from lit-
erature, out of which one molecule is N -ethylmaleimide (NEM)
and the other three were its analogs. All the molecules were com-
putationally designed using Marvin Sketch 5.2 and subsequently,
geometrically optimized using three-dimensional cleaning utility
(ChemAxon LLC, 2008).
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Protein-small molecule docking
Active site residues predicted from sequence alignment was spec-
iﬁed for active site directed molecular docking. Ligand dataset
under study were docked separately into the binding site of the
receptor using PATCHDOCK (Duhovny et al., 2005). PATCH-
DOCK performs docking simulations in three phases viz. mole-
cular shape representation, surface patch matching, and ﬁnally,
ﬁltering and scoring. Molecular shape representation step ini-
tially computes the molecular surface of given molecule, followed
by detection of geometric patches using segmentation algorithm.
Surface patchmatching stage applies geometric hashing and pose-
clustering techniques to match the ﬁltered-hot spot residues con-
taining patches. The candidate molecule is reﬁned at last from
patch penetration between ligand and receptor molecules and
ranked by shape complementarity score in its ﬁnal stage.
RESULTS
NP EPITOPE PREDICTIONS
Epitope prediction for the NP showed regions spanning the
sequence between positions 39 and 125, and scored well when
all the scales were considered (Figure 2). Kolaskar and Ton-
gaonkar antigenicity scale predicted a 24 length peptide in the
positions 16–39. When all the scales were taken into considera-
tion, this peptide did not show any signiﬁcance in terms of surface
accessibility, ﬂexibility, and hydrophobicity/hydrophilicity. Simi-
lar setback occurred when a Bepipred linear epitope prediction
showed an 11 length peptide in the positions of 8–18, which is in
low signiﬁcance region. Therefore, these two predicted epitopes
were discarded. Peptides in the sequence positions 42–48, 68–77,
79–88, and 104–125 predicted using Kolaskar and Tongaonkar
antigenicity scale displayed antigenicity. Further,Bepipred analysis
(B-cell epitope prediction) revealed a continuous predicted epi-
tope with 13 amino acid residues in the sequence positions 56–68
(Table 1). Beside, we found that these predicted epitope regions
were observed in the surface of themodeledNPprotein.Hence, the
region spanning the sequence positions of 42–48, 56–68, 68–77,
and 79–88 will be of greater importance for epitope-based vaccine
design.
HLA BINDING PEPTIDES PREDICTIONS OF NP AND OTU DOMAIN
Nucleocapsid protein and OTU domain sequences generated 141
and 179 nanomers, respectively. Promiscuous HLA binders are
those peptides which bind most HLA alleles and its respective
sub-alleles with increased afﬁnity. Prediction of promiscuousHLA
peptide binders displayed similarity as well as variation. Dissim-
ilar pattern was found in NP analysis. For example, H-2Db and
H-2Dd alleles expressed different peptides, 96-RVNANTAAL-104
and 71-VEVPKIEQL-79. Similar peptide prediction was observed
in OTU domain sequence (PDB ID: 3PT2 chain A). For example,
HLA-B7 and B8 alleles exhibited similar peptide 81-EARLVGLSL-
89 (Table 2). Despite the use of scoring system of Tmhcpred server
to rank its predictions, an in vitro and pharmacogenetic study will
help to detect promiscuous HLA binders.
PROTEIN–PROTEIN DOCKING STUDY OF MxA–NP PROTEINS
Among the 10 plausible candidate structures generated, a best ab
initio model for the NP was selected using Ramachandran plot.
FIGURE 2 | Epitope prediction of NP using (A) Emini surface
accessibility prediction (threshold:1.000), (B) Karplus and Schulz
flexibility prediction (threshold:1.000), (C) Kolaskar andTongaonkar
antigenicity prediction (threshold:1.000), (D) Parker hydrophilicity
prediction (threshold:1.678), and (E) Kyte and Doolittle hydrophobicity
prediction (threshold:0.000).
Selected model exhibited 98% amino acids in allowed regions
with the exception of two outliers (Figure 3A). Subsequently, the
selected model displayed the structure with energy minimized to
−5760.383KJ/mol (Figure 3B).
In order to evade blind docking of MxA protein, functional
site identiﬁcation was carried out to understand the region of
protein interaction sites (Figure 4A). It is well known that MxA
protein is a homodimer of unique chains. Dimer interface site
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Table 1 | Predicted epitopes of NP protein via Kolaskar andTongaonkar
antigenicity scale (S.no. 1–5) and Bepipred continuous epitope
predictions (S.no. 6 and 7).
S.no. Start
position
End
position
Peptide Peptide
length
1 16 39 DSIYASALVEATKFCAPIYECAWA 24
2 42 48 TGIVKKG 7
3 68 77 ELKVEVPKIE 10
4 79 88 LSNYQQAALK 10
5 104 125 LSNKVLAEYKVPGEIVMSVKEM 22
6 8 18 SATDDAQKDSI 11
7 56 68 AGTIKSWDESYTE 13
Table 2 | Predicted HLA binding peptides of selected alleles (only
highly scored peptides were reported here).
Allele Start
position
End
position
Peptide Score
HLA BINDING PEPTIDES OF NP PROTEIN
H-2Db 96 104 RVNANTAAL 200.000
H-2Dd 71 79 VEVPKIEQL 6.000
H-2Ld 114 122 VPGEIVMSV 60.000
H-2Kb 61 69 SWDESYTEL 5.280
H-2Kd 51 59 WFEKNAGTI 960.000
H-2Kk 110 118 AEYKVPGEI 1000.000
HLA BINDING PEPTIDES OF OTU DOMAIN SEQUENCE
HLA-A1 67 75 LTESAARKY 112.500
HLA-A2 27 35 NISDYFEIV 214.613
HLA-A24 43 51 CFYHSIAEL 22.000
HLA-A3 86 94 GLSLEDYLK 180.000
HLA-A2.1 171 179 ALSLMDRVI 118.300
HLA-B14 176 184 DRVIAVDQL 360.000
HLA-B40 100 108 NEWGSTLEA 40.000
HLA-B*5101 111 119 LAKEMGITI 314.600
HLA-DRB1*0101 158 166 LRILPQFET 1.900
HLA-B*51 53 61 MPNKTDHSY 131.670
HLA-B60 89 97 LEDYLKRML 176.000
HLA-B7 81 89 EARLVGLSL 120.000
HLA-B8 81 89 EARLVGLSL 32.000
H-2Db 85 93 VGLSLEDYL 8.580
H-2Dd 150 158 SGQTHFDAL 86.400
H-2Kb 150 158 SGQTHFDAL 47.520
H-2Kd 43 51 CFYHSIAEL 1152.000
H-2Kk 113 121 KEMGITIII 500.000
H-2Ld 37 45 QPGDGNCFY 78.000
was predicted to be non-interacting site since it is required for its
dimerization. The regions exposed to solvent were predicted to be
entirely accessible for protein–protein interaction. Further, MSA
of MxA protein with its close sequence homology revealed similar
results. Hence, regions excluding dimer interface was utilized as
potential receptor-interaction site for protein–protein docking.
Protein–protein docking simulations with MxA protein as
receptor and modeled NP as ligand molecule was also performed.
Among the best 10 docked conformations, a best docked
conformation (Figure 4B) was selected in which the docked
regions between two proteins exhibited signiﬁcant surface com-
plementarity. To examine the possibility of any penetrations
between two molecules, the selected conformation was manu-
ally studied using standard three-dimensional protein structure
visualizer.
Further, this docking simulation was repeated using Clus-
Pro protein–protein docking program to conﬁrm the interac-
tions of MxA–NP protein. Rigid body dock PIPER program
yielded a weighted score of −1066.40 Kcal/mol whereas Clus-
Pro provided a largest cluster (ﬁrst cluster as per rank) in
which 154 docked conformations were found with cluster cen-
ter scored −923.80 Kcal/mol. The variation observed in the
energy value of lowest energy docked conformer with its clus-
ter centered conformer was −142.60 Kcal/mol. The comparative
analysis of the docked conformations generated from GRAMM-
X and ClusPro showed that the interacting site was found to
be the MxA protein’s dimer interface and in good correspon-
dence with the predictions of ConSurf server. Such studies on
expression level of human MxA protein in CCHFV infected
human subjects will help us to demonstrate that a puriﬁed
MxA protein usually a product of recombinant genetic engi-
neering will be a best candidate for CCHFV vaccinomics, if the
MxA protein expression in infected human cells is expected to
below.
PROTEIN-SMALL MOLECULE DOCKING OF VIRAL OTU DOMAIN
Active site prediction of OTUdomainwas achieved using sequence
and structure-based approaches. MSA of OTU domain with
human otubains 1 and 2 revealed that a conserved pattern,
DGNCFY was preserved in these cysteine proteases. The MSA
analysis (Figure 5A) showed that the active site consisted of Asp40
and Cys43. Further, structure-based active site prediction was
made to ﬁnd whether the conserved pattern containing the two
active site residues, Asp40 and Cys43, is exposed or buried. It was
observed that conserved motif is exposed and solvent accessible
(Figure 5B).
Small inhibitor molecules targeting the active site residues will
be of greater importance for designing speciﬁc inhibitors for viral
OTU domain. Since OTU domain belongs to cysteine protease
family and has DUB activity, the literature survey could not reveal
any DUB small molecule inhibitors. Hence, search was carried
on for cysteine protease small molecule inhibitors having proven
inhibitory activity and the potential to modify active site cysteine
residue (Singh and Liu, 2000). N -ethylmaleimide (NEM) and
its analogs, N -Phenyl maleimide (NPM), N,N ′-(1,2-phenylene)
dimaleimide (NNPD) andN -(1-pyrenyl)maleimide (NPYM)was
used as ligand dataset (Figure 6). Conserved motif was employed
as active site residues (residues: 37–42) for active site directed
docking procedure using PATCHDOCK. Among the 200 docked
conformations generated for each procedure, best conformation
was selected using the shape complementarity score and area of
docking translations (Table 3; Figure 6). Due to non-speciﬁcity
of potent cysteine proteases having the ability to harm all the
cellular proteins exposing cysteine residues on surface, there arises
a requirement of potent cysteine protease inhibitors which should
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FIGURE 3 | Energy minimized structure of NP. (A) Ramachandran plot favoring 98% in allowed regions with the exception of two outliers (boxed regions) and
(B) ab initio model.
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FIGURE 4 | (A) Predicted MxA protein functional site (only one chain shown).
Conserved regions >90% (dark purple) and 80–89% (pink color) in MSA
alignment with its close sequence homologs (B) MxA protein (surface with
electrostatic potential) as docked with NP (surface with B factor).
FIGURE 5 | Conserved pattern DGNCFY (boxed) around active site
residues, (A) Asp40 and Cys43 (B) Spacefill model of OTU domain
showing conserved pattern (shown as patch).
Table 3 | Docking results of OTU domain with NEM and its analogs.
Compound Score Area
N -ethylmaleimide (NEM) 1704 178.70
N -phenyl maleimide (NPM) 2104 216.30
N,N ′-(1,2-phenylene) dimaleimide (NNPD) 2504 282.80
N -(1-pyrenyl) maleimide (NPYM) 3030 341.30
target the complete conservedmotif. On the other hand, fragment
based and de novo drug design of DUB inhibitors will prove to
be a best drug candidate to treat against this deadliest CCHFV
infection.
DISCUSSION
The present study was focused on in silico epitope-based
immunoinformatics and molecular docking against the CCHFV
deadliest virus. Despite the hindrances to initiate research on
CCHFV as it requires biosafety level-4 (BSL-4), the high path-
ogenicity to establish endemic and the non-availability of effective
treatments poses a great threat to human community. These pre-
dicted epitopes may play a highly informative and crucial role in
antidote production against CCHFV. Common antigenic peptides
are also important for synthetic peptide vaccine production or
antidote production. Similarly, small molecule based drug design-
ing can also be initiated simultaneously. Highly speciﬁc NEM
analogs and/or DUB inhibitors designed using fragment based
or de novo approaches will prove to be the best drug candidates to
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FIGURE 6 |Two-dimensional structure of ligands and respective docked conformations with OTU domain (A) N-ethylmaleimide (NEM), (B) N-phenyl
maleimide (NPM), (C) N,N ′-(1,2-phenylene) dimaleimide (NNPD), and (D) N-(1-pyrenyl) maleimide (NPYM).
establish effective treatment against this infection. The real con-
sequences will arise if this pathogenic form takes the form of a
biological warfare as similar to Anthrax. We hope that our cur-
rent ﬁndings would help the pharmacologists as well as scientiﬁc
research bodies to instigate research on this very recent outbreak.
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